Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.13
+0.02 (0.28%)
Mar 9, 2026, 1:29 PM EDT - Market open
ARCT Market Cap
ARCT has a market cap or net worth of $202.66 million as of March 9, 2026. Its market cap has decreased by -55.78% in one year.
Market Cap
202.66M
Enterprise Value
-3.82M
1-Year Change
-55.78%
Ranking
Category
Stock Price
$7.13
Market Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $202.66M, an increase of 96.75%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 202.10M | 16.02% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 216.84M |
| Humacyte | 214.23M |
| Cibus | 213.48M |
| Protalix BioTherapeutics | 210.70M |
| ProMIS Neurosciences | 209.84M |
| Elicio Therapeutics | 203.23M |
| Acumen Pharmaceuticals | 200.50M |
| Galectin Therapeutics | 199.87M |